Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Sarepta Therapeutics, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on precision genetic medicine for rare diseases. The company develops RNA-targeted therapeutics and gene therapy candidates, particularly for Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies. It has multiple approved treatments and a robust pipeline of investigational therapies.